Chemotherapy directly followed by poly(ADP-ribose) polymerase inhibition as an alternative to surgery in patients with BRCA-mutated ovarian cancer: a potential management strategy in the era of coronavirus disease 2019

Saved in:
Bibliographic Details
Published in:American journal of obstetrics and gynecology 2020-09, Vol.223 (3), p.469-470
Main Authors: Vetter, Monica Hagan, Smrz, Stacy A., Copeland, Larry J., Cohn, David E.
Format: Article
Language:English
Subjects:
Antineoplastic Agents - therapeutic use
Betacoronavirus
Carcinoma, Ovarian Epithelial - drug therapy
Carcinoma, Ovarian Epithelial - genetics
Coronavirus Infections - epidemiology
COVID-19
Female
Genes, BRCA1
Genes, BRCA2
Humans
Letter to the Editor
Mutation
Ovarian Neoplasms - drug therapy
Ovarian Neoplasms - genetics
Pandemics
Pneumonia, Viral - epidemiology
Poly(ADP-ribose) Polymerase Inhibitors - therapeutic use
SARS-CoV-2
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0002-9378
1097-6868
1097-6868
DOI:10.1016/j.ajog.2020.05.037